Evaluation of the Effect of Radiotherapy Timing on Toxicity in HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine During the Adjuvant Period

Aim: Breast cancer is the second leading cause of cancer-related deaths in women. Approximately 20-25% of breast cancers express HER2 and are associated with poor prognosis. With the use of HER2-targeted therapies, there has been an increase in treatment success for breast cancer cells overexpressin...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	İlknur Deliktaş Onur, Oğuzcan Kınıkoğlu, Gözde Kavgacı, Ömer Faruk Kuzu, Tuğba Başoğlu, Öztürk Ateş, Cengiz Karaçin
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Ankara Hematology Oncology Association 2025-04-01
Reeks:	Acta Haematologica Oncologica Turcica
Onderwerpen:	antibody-drug conjugates adjuvant t-dm1 trastuzumab extensive her2-positive breast cancer
Online toegang:	https://actaoncologicaturcica.com/articles/evaluation-of-the-effect-of-radiotherapy-timing-on-toxicity-in-her2-positive-breast-cancer-receiving-trastuzumab-emtansine-during-the-adjuvant-period/doi/ahot.galenos.2024.15921
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!